Alicia Vogleson
Family · Wilmington, DENPI 1952825168
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 59 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in DE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 59 payments — averaging $63.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$527
- AstraZeneca$527
- Novo Nordisk$233
- Johnson & Johnson$219
- Lilly USA, LLC$201
- Boehringer Ingelheim$196
- plus $2K from 18 others
What the payments were for
- Food & beverage$3,726100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 5 | $527 |
| AstraZeneca | 7 | $527 |
| Novo Nordisk | 8 | $233 |
| Johnson & Johnson | 2 | $219 |
| Lilly USA, LLC | 5 | $201 |
| Boehringer Ingelheim | 2 | $196 |
| Sage Therapeutics, LLC | 2 | $195 |
| Pfizer | 5 | $194 |
| Astellas Pharma US Inc | 4 | $183 |
| AbbVie | 2 | $155 |
| GSK | 2 | $138 |
| Xeris Pharmaceuticals, Inc. | 1 | $122 |
| Amgen | 1 | $120 |
| Regeneron | 1 | $117 |
| Dexcom, Inc. | 1 | $114 |
| Rigel Pharmaceuticals, Inc. | 1 | $105 |
| Alkermes, Inc. | 1 | $72 |
| Otsuka America Pharmaceutical, Inc. | 1 | $72 |
| Tactile Systems Technology Inc | 1 | $67 |
| Qiagen, LLC | 1 | $64 |
| Exact Sciences | 2 | $39 |
| Merck | 2 | $33 |
| Novartis | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,726 in reported general payments places this provider in the 90th percentile of 523 family providers in Delaware.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 14 | $9,579 |
| TradjentaLinagliptin | 11 | $6,224 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 47 | $1,828 |
| Rosuvastatin Calcium | 51 | $1,503 |
| Atorvastatin Calcium | 73 | $1,097 |
| Metoprolol Succinate | 36 | $597 |
| Ventolin HfaAlbuterol Sulfate | 11 | $594 |
| Levothyroxine Sodium | 59 | $545 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 13 | $516 |
| Fluticasone Propionate | 20 | $433 |
| Amlodipine Besylate | 43 | $381 |
| Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide | 15 | $358 |
| Omeprazole | 37 | $343 |
| Lisinopril | 34 | $303 |
| Sertraline Hcl | 18 | $260 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $194 | $9,57914 claims |
| Boehringer IngelheimTradjenta | $196 | $6,22411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 523 family providers in Delaware.
Other family in Wilmington
- Tracy EstesWilmington$59K
- Jodi KahanWilmington$21K
- Elizabeth Sharp-AsiyoWilmington$13K
- Shannon HogateWilmington$10K
- Carolyn BarrettWilmington$10K
- Gloria DiazWilmington$8K
- Amy HitchensWilmington$8K
- Emmanuel AntonioWilmington$7K
- Stephanie Evans MitchellWilmington$6K
- Sidonie SalmonWilmington$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.